Lyra Therapeutics, Inc.
LYRA
Revenue
598.00k
▲66.00k▲12.41%
3 Months ChangeAssets
94.58M
▼-46.95M▼-33.17%
3 Months ChangeLiabilities
63.61M
▼-418.00k▼-0.6529%
3 Months ChangeFree Cash Flow
-24.60M
▼-8.71M▼-54.79%
12 Months ChangeRevenue/Cost Of Revenue
Revenue
Cost Of Revenue
Loading...
| Date | Revenue | Cost Of Revenue |
|---|---|---|
Net Profit/Loss
Net Profit/Loss
Baseline
Loading...
| Date | Net Profit/Loss |
|---|---|
Assets/Liabilities
Assets
Liabilities
Loading...
| Date | Assets | Liabilities |
|---|---|---|
Cash Flows
Operating (Cash Flow)
Investing (Cash Flow)
Financing (Cash Flow)
Free Cash Flow
Loading...
| Date | Operating (Cash Flow) | Investing (Cash Flow) | Financing (Cash Flow) | Free Cash Flow |
|---|---|---|---|---|
EPS
EPS (Diluted)
Loading...
| Date | EPS | EPS (Diluted) |
|---|---|---|
Outstanding Shares
Loading...
| Date | Outstanding Shares |
|---|---|
Recent 8-K/10-Q Filings
2024-08-14
Form 10-Q
ID: 0000950170-24-097042
2024-08-14
Form 8-K
ID: 0000950170-24-097007
2024-07-23
Form 8-K
ID: 0001193125-24-182860
2024-06-18
Form 8-K
ID: 0001193125-24-163395
2024-05-21
Form 8-K
ID: 0001193125-24-143419
2024-04-30
Form 10-Q
ID: 0000950170-24-050535
2024-04-30
Form 8-K
ID: 0000950170-24-050525
2024-04-19
Form 8-K
ID: 0001193125-24-102914
2024-03-21
Form 8-K
ID: 0000950170-24-034701
2024-03-01
Form 8-K
ID: 0000950170-24-023918